Sun Pharmaceutical Industries Limited
₹1,768.2
INR-10.80(-0.61%)
As of November 14, 2024 10:00:00 AMSun Pharmaceutical Industries Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹1764.05
High: ₹1794.1
All time High
The highest price the stock has ever reached since being listed
₹1948.70
Price Change 1h
Price change in the last hour of trading
+₹-21.50 +-1.20%
Price Change 1d
Price change over the last trading day
+₹-21.50 +-1.20%
Price Change 1w
Price change over the last week of trading
+₹-41.40 +-2.29%
Sun Pharmaceutical Industries Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
444379.90 Cr
About Sun Pharmaceutical Industries Limited Share
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
43000
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside
- Sun Pharma Q2 Results: Profit rises 28% YoY to Rs 3,040 crore, beats estimates
- Sun Pharma Q2 Results: Net profit rises 28% YoY to ₹3,040.16 crore | Stock Market News
- Sun Pharma shares fall 5% post Leqselvi injunction, but analysts say opportunity 'not over'
- Buy Sun Pharmaceutical Industries, target price Rs 1995: JM Financial
Sun Pharmaceutical Industries Limited Resource
FAQs
The current price of Sun Pharmaceutical Industries Limited is INR 1768.20 — it has changed by -1.20% in the past 24 hours. Watch Sun Pharmaceutical Industries Limited's stock price performance more closely on the chart.
Sun Pharmaceutical Industries Limited has a market capitalization of 4443799027712 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sun Pharmaceutical Industries Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Sun Pharmaceutical Industries Limited stocks are traded under the ticker SUNPHARMA
As of November 15, 2024, the company has 43000 employees.